In this study, using RNA-seq data of 576 HCC patients, a panel of seven genes (including LCP2, TYROBP, ZAP70, PTPRC, FYN, WAS and NCF4) has been identified which are independent predictors of delayed tumor recurrence and improved patient prognosis. This evidence concerns the gene LCP2 and neoplasm.